Biomedical Engineering Reference
In-Depth Information
Nasu T, Ito H, Tsutsumi R, Kitaori T, Takemoto M, Schwarz E, Nakamura T.
Biological activation
of bone-related biomaterials by recombinant adeno-associated virus vector.
J Orthop Res
2009;27(9):1162-8.
Neamnark A, Suwantong O, Bahadur R, Hsu C, Supaphol P, Uludag H.
Aliphatic lipid substitution
on 2 kDa polyethylenimine improves plasmid delivery and transgene expression
. Mol Pharm
2009;6(6):1798-815.
Oda M, Kuroda S, Kondo H, Kasugai S.
Hydroxyapatite fiber material with BMP-2 gene induces
ectopic bone formation
. J Biomed Mat Res Part B 2009;90(1):101.
Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S.
Osteoinduction by bone morphogenetic
protein-2 via adenoviral vector under transient immunosuppression
. Biochem Biophys Res
Commun 2000;267(1):382-7.
Okubo Y, Bessho K, Fujimura K, Kaihara S, Iizuka T, Miyatake S.
The time course study of
osteoinduction by bone morphogenetic protein-2 via adenoviral vector
. Life Sci
2001a;70:325-336.
Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S.
In vitro and in vivo studies of a bone
morphogenetic protein-2 expressing adenoviral vector
. J Bone Joint Surg Am 2001b;83-
A:S99-104.
Ono I, Yamashita T, Jin HY, Ito Y, Hamada H, Akasaka Y, Nakasu M, Ogawa T, Jombow K.
Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene
therapy
. Biomaterials 2004;25:4709-4718.
Osawa K, Okubo Y, Nakao K, Koyama N, Bessho K.
Osteoinduction by microbubble-enhanced
transcutaneous sonoporation of human bone morphogenetic protein-2
. J Gene Med.
2009;11(7):633-41.
Pante N, Kann M.
Nuclear pore complex is able to transport macromolecules with diameters of
~39 nm
. Mol Biol Cell 2002;13:425-34.
Pechan P, Herrlinger U, Aghi M, Jacobs A, Breakefield X.
Combined HSV-1 recombinant and
amplicon piggyback vectors: Replication-competent and defective forms, and therapeutic
efficacy for experimental gliomas.
J Gene Med. 1999;1(3):176-85.
Pichon C, Goncalves C, Midoux P.
Histidine-rich peptides and polymers for nucleic acids deliv-
ery
. Adv Drug Deliv Rev. 2001;53(1):75-94.
Pizzato M, Marlow S, Blair E, Takeuchi Y.
Initial binding of murine leukemia virus particles to
cells does not require specific env-receptor interaction
. J Virol. 1999;73(10):8599.
Pollard H, Remys JS, LoussouarnG, Demolombe S, Behr JP.
Polyethylenimine but not cationic
lipids promotes transgene delivery to the nucleus in mammalian cells
. J Biol Chem1998;
273(13):7507-7511.
Porter J, Ruckh T, Popat K.
Bone tissue engineering: a review in bone biomimetics and drug
delivery strategies.
Biotechnol Prog 2009;25(6):1539-1560.
Qing K, Mah C, Hansen J, Zhou S, Dwarki V.
Human fibroblast growth factor receptor 1 is a
co-receptor for infection by adeno-associated virus 2
. Nat Med. 1999;5(1):71-77.
Rentsendorj A, Agadjanian H, Chen X, Cirivello M, MacVeigh M, Kedes L, et al.
The Ad5 fiber
mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry
pathway
. Gene Ther. 2004;12(3):225-37.
Rentsendorj A, Xie J, MacVeigh M, Agadjanian H, Bass S, Kim D, et al.
Typical and atypical
trafficking pathways of Ad5 penton base recombinant protein: Implications for gene transfer
.
Gene Ther. 2006;13(10):821-36.
Rittner K, Benavente A, Bompard-Sorlet A, Heitz F.
New basic membrane-destabilizing peptides
for plasmid-based gene delivery in vitro and in vivo
. Molecular Therapy. 2002;5(2):104-114.
Roe T, Reynolds T, Yu G, Brown P.
Integration of murine leukemia virus DNA depends on mitosis.
EMBO J. 1993;12(5):2099.
Rosen V.
BMP2 signaling in bone development and repair
. Cytokine Growth Factor Rev
2009;20(5-6):475-80.
Rudolph C, Plank C, Lausier J, Schillinger U, Muller R, Rosenecker J.
Oligomers of the arginine-
rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells
. J Biol
Chem. 2003;278(13):11411.
Search WWH ::
Custom Search